As described in the Section entitled “Computational redesign of the c-Raf-RBD:KRas protein-protein interface,” KRas is an important cancer target that has been heavily studied and exhibits a thoroughly optimized protein-protein interface in its interactions with its effectors [47–59]. Here, RAF1 is linked to cancer.